Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
Background: Clinical trials have shown low-molecular weight heparin (LMWH) to be at least as safe and efficacious as unfractionated heparin (UFH) for preventing venous thromboembolism (VTE) in acutely-ill medical inpatients.ObjectiveTo compare clinical and economic outcomes among acutely-ill medical inpatients receiving the LMWH enoxaparin versus UFH prophylaxis in clinical practice. Methods: Using a large, multi-hospital, US database, we identified persons aged 40 years hospitalized for 6 days for an acute medical condition (including circulatory disorders, respiratory disorders, infectious diseases, or neoplasms) from Q4 1999 to Q1 2002. From these patients, those who received thromboprophylaxis with either enoxaparin or UFH were identified. Surgical patients and those requiring or ineligible for anticoagulation were excluded. We compared the incidence of deep-vein thrombosis (DVT), pulmonary embolism (PE), and all VTE (i.e., DVT and/or PE). Secondary outcomes were occurrence of side-effects, length of hospital stay and total costs. RESULTS: 479 patients received enoxaparin prophylaxis and 2,837 received UFH. The incidence of VTE was 1.7% with enoxaparin prophylaxis versus 6.3% with UFH (RR = 0.26; p < 0.001). Occurrence of side effects, length of stay (10.00 days with enoxaparin vs. 10.26 days with UFH; p = 0.348) and total costs ($18,777 vs. $17,602; p = 0.463) were similar in the 2 groups. Conclusion: We observed a 74% lower risk of VTE among patients receiving enoxaparin prophylaxis versus UFH prophylaxis. There was no significant difference in side effects or economic outcomes. These results provide evidence that the LMWH enoxaparin is more effective than UFH in reducing the risk of VTE in current clinical practice.
Tivoli Audio iPAL Portable Audio Laboratory AM/FM Radio with Speaker (Silver/White)
Tivoli Audio iPAL Portable Audio Laboratory AM/FM Radio with Speaker (Silver/White) New electronics that resemble old electronics are all the rage these days. With a case that looks like it belongs in a mad scientist’s laboratory, the Tivoli iPal is on the vanguard of retro style. In fact, the “Pal” stands for Portable Audio […]
[Item]: Standard 23 x 36 [Additional Info]: UNDERPAD,POLYMER,STANDARD,23X36,10/10S HCPC # A4554-NOT COVERED BY-OR VALID FOR MEDICARE CHECK WITH YOUR STATE TO SEE IF UNDERPADS ARE COVERED UNDER THEIR MEDICAID PROGRAM.
[Item]: Standard 23″ x 36″ [Additional Info]: UNDERPAD,POLYMER,STANDARD,23X36,10/10S HCPC # A4554-NOT COVERED BY-OR VALID FOR medicare CHECK WITH YOUR STATE TO SEE IF UNDERPADS ARE COVERED UNDER THEIR medicaid PROGRAM. Item: Standard 23″ x 36″ Additional Info: Medline Protection Plus Disposable Underpads with Polymer Holds Fluids. Eliminate waste with Medline Protection Plus […]
Benign intracranial hypertension associated to blood coagulation derangements
Background: Benign Intracranial Hypertension (BIH) may be caused, at least in part, by intracranial sinus thrombosis. Thrombosis is normally due to derangements in blood coagulation cascade which may predispose to abnormal clotting activation or deficiency in natural inhibitors’ control. The aim of the study is to examine the strength of the association between risk factors for thrombosis and BIH.Patients and methodsThe incidence of prothrombotic abnormalities among a randomly investigated cohort of 17 patients with BIH, was compared with 51 healthy subjects matched for sex, age, body mass index, height and social background. Results: The number of subjects with protein C deficiency was significantly higher in patients than in controls (3 vs 1, p < .001; Fisher Exact Test). Moderate to high titers of anticardiolipin antibodies ( 2-Glycoprotein type I) were found in 8 out of 17 patients.Increased plasma levels of prothrombin fragment 1+2, fibrinopeptide A (FPA), and PAI-1 were demonstrated in patients group (5.7 1.15 nM vs 0.45 0.35 nM; 8.7 2.5 ng/mL vs 2.2 1.25 ng/mL; 45.7 12.5 ng/mL vs 8.5 6.7 ng/mL, respectively; p < .001; Fisher Exact Test). Gene polymorphisms for factor V Leiden mutation, prothrombin mutation 20210 A/G, MTHFR 677 C/T, PAI-1 4G/5G, ACE I/D were detected in 13 patients.DiscussionIn agreement with other authors our data suggest a state of hypercoagulability in BIH associated with gene polymorphisms. Our findings also showed that mutations in cardiovascular genes significantly discriminate subjects with a BIH history. The association between coagulation and gene derangements, usually regarded to as cryptogenic, may suggest a possible pathogenetic mechanism in BIH. So, a prothrombotic tendency may exist that would, at least in part, explain some cases of BIH.Although based on a small population, these findings raise the exciting possibility of using these haemostatic factors as markers for selecting high-risk subjects in BIH disease.
Waring JEX328 health Juice Extractor
Waring JEX328 health Juice Extractor Drink to your heart’s content with this super juicer from Waring. Its ultra-efficient juice extraction method allows you to capture more of the essence of every piece of fruit or vegetable you feed into the machine. Comes with an extra-large, 3-1/2″ feed tube and 32 oz. stainless steel juice […]
Guide to baby s first year from iVillage. Find
Guide to baby’s first year from iVillage. Find out about topics like infant development, safety issues, teething, crying, nutrition, breastfeeding, and other … Sony Electronics: Official Online Store - shop today and Save Find over 1,000 Sony Products including: VAIO Desktops, VAIO Notebooks, Digital Cameras, Camcorders, Televisions, Home Audio/Video, and more. Exclusive Online Offers … Purchase Your […]
3 Responses to “Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients”
Leave a Reply
You must be logged in to post a comment.

April 27th, 2007 at 1:59 am
[…] Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients Background: Clinical trials have shown low-molecular weight heparin (LMWH) to be at least as safe and efficacious as unfractionated heparin (UFH) for preventing venous thromboembolism (VTE) in acutely-ill medical inpatients.ObjectiveTo compare clinical and economic outcomes among acutely-ill medical inpatients receiving the LMWH enoxaparin versus UFH prophylaxis in clinical practice. Methods: Using a large, multi-hospital, US […] […]
April 27th, 2007 at 10:38 am
[…] Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients Background: Clinical trials have shown low-molecular weight heparin (LMWH) to be at least as safe and efficacious as unfractionated heparin (UFH) for preventing venous thromboembolism (VTE) in acutely-ill medical inpatients.ObjectiveTo compare clinical and economic outcomes among acutely-ill medical inpatients receiving the LMWH enoxaparin versus UFH prophylaxis in clinical practice. Methods: Using a large, multi-hospital, US […] […]
August 15th, 2008 at 7:31 pm
Debt Relief…
just stopped in. good site….